Direct Binding of Activated c-Src to the β3-Adrenergic Receptor Is Required for MAP Kinase Activation

Both β2- and β3-adrenergic receptors (ARs) are able to activate the extracellular signal-regulated kinase (ERK) pathway. We previously showed that c-Src is required for ERK activation by β2AR and that it is recruited to activated β2AR through binding of the Src homology 3 (SH3) domain to proline-rich regions of the adapter protein β-arrestin1. Despite the absence of sites for phosphorylation and β-arrestin binding, ERK activation by β3AR still requires c-Src. Agonist activation of β2AR, but not β3AR, led to redistribution of green fluorescent protein-tagged β-arrestin to the plasma membrane. In β-arrestin-deficient COS-7 cells, β-agonist-dependent co-precipitation of c-Src with the β2AR required exogenous β-arrestin, but activated β3AR co-precipitated c-Src in the absence or presence of β-arrestin. ERK activation and Src co-precipitation with β3AR also occurred in adipocytes in an agonist-dependent and pertussis toxin-sensitive manner. Protein interaction studies show that the β3AR interacts directly with the SH3 domain of Src through proline-rich motifs (PXXP) in the third intracellular loop and the carboxyl terminus. ERK activation and Src co-precipitation were abolished in cells expressing point mutations in these PXXP motifs. Together, these data describe a novel mechanism of ERK activation by a G protein-coupled receptor in which the intracellular domains directly recruit c-Src. Both β2- and β3-adrenergic receptors (ARs) are able to activate the extracellular signal-regulated kinase (ERK) pathway. We previously showed that c-Src is required for ERK activation by β2AR and that it is recruited to activated β2AR through binding of the Src homology 3 (SH3) domain to proline-rich regions of the adapter protein β-arrestin1. Despite the absence of sites for phosphorylation and β-arrestin binding, ERK activation by β3AR still requires c-Src. Agonist activation of β2AR, but not β3AR, led to redistribution of green fluorescent protein-tagged β-arrestin to the plasma membrane. In β-arrestin-deficient COS-7 cells, β-agonist-dependent co-precipitation of c-Src with the β2AR required exogenous β-arrestin, but activated β3AR co-precipitated c-Src in the absence or presence of β-arrestin. ERK activation and Src co-precipitation with β3AR also occurred in adipocytes in an agonist-dependent and pertussis toxin-sensitive manner. Protein interaction studies show that the β3AR interacts directly with the SH3 domain of Src through proline-rich motifs (PXXP) in the third intracellular loop and the carboxyl terminus. ERK activation and Src co-precipitation were abolished in cells expressing point mutations in these PXXP motifs. Together, these data describe a novel mechanism of ERK activation by a G protein-coupled receptor in which the intracellular domains directly recruit c-Src. G protein-coupled receptor mitogen-activated protein β2/β3-adrenergic receptor extracellular signal-regulated kinase pertussis toxin GPCR kinase Src homology 3 glutathione S-transferase green fluorescent protein During the past several years, transmembrane signaling traffic through G protein-coupled receptors (GPCRs) 1 has grown from the classic G protein effectors such as adenylyl cyclase and phospholipases to include novel mechanisms for activation of mitogen-activated protein (MAP) kinase cascades. These signaling systems typically involve receptor and non-receptor tyrosine kinases as scaffolds and intermediaries (1Koch W. Hawes B. Allen L. Lefkowitz R. Proc. Natl. Acad. Sci. , U. S. A. 1994; 91: 12706-12710Crossref PubMed Scopus (409) Google Scholar, 2van Biesen T. Hawes B. E. Luttrell D. K. Krueger K. M. Touhara K. Porfiri E. Sakaue M. Luttrell L. M. Lefkowitz R. J. Nature. 1995; 376: 781-784Crossref PubMed Scopus (526) Google Scholar, 3Crespo P. Xu N. Simonds W. F. Gutkind J. S. Nature. 1994; 369: 418-420Crossref PubMed Scopus (766) Google Scholar, 4van Biesen T. Luttrell L. M. Hawes B. E. Lefkowitz R. J. Endocr. Rev. 1996; 17: 698-714Crossref PubMed Scopus (390) Google Scholar, 5Lefkowitz R. J. J. Biol. Chem. 1998; 273: 18677-18680Abstract Full Text Full Text PDF PubMed Scopus (908) Google Scholar, 6Gutkind, J. S. (2000) Science's STKEww. stke. org/cgi/content/full/OCₛigtrans; 2000/40/rel. Google Scholar). An example of this flexibility in GPCR signaling includes the β2-adrenergic receptor (β2AR). Although this receptor is classically known to couple to Gs and stimulate adenylyl cyclase, it can also activate the ERK1/2 MAP kinase pathway (7Daaka Y. Luttrell L. M. Lefkowitz R. J. Nature. 1997; 390: 88-91Crossref PubMed Scopus (1077) Google Scholar, 8Maudsley S. Pierce K. L. Zamah A. M. Miller W. E. Ahn S. Daaka Y. Lefkowitz R. J. Luttrell L. M. J. Biol. Chem. 2000; 275: 9572-9580Abstract Full Text Full Text PDF PubMed Scopus (386) Google Scholar). In some cell types, the β2AR activates ERK through its coupling to a PTX-sensitive Gi protein and subsequent Ras-dependent MAP kinase activation (7Daaka Y. Luttrell L. M. Lefkowitz R. J. Nature. 1997; 390: 88-91Crossref PubMed Scopus (1077) Google Scholar, 9Soeder K. S. Snedden S. K. Cao W. Della Rocca G. J. Daniel K. W. Luttrell L. M. Collins S. J. Biol. Chem. 1999; 274: 12017-12022Abstract Full Text Full Text PDF PubMed Scopus (161) Google Scholar), whereas in other systems this occurs in a PTX-independent and a Gs- and cAMP-dependent process (10Wan Y. Huang X. -Y. J. Biol. Chem. 1998; 273: 14533-14537Abstract Full Text Full Text PDF PubMed Scopus (77) Google Scholar, 11Schmitt J. M. Stork P. J. S. J. Biol. Chem. 2000; 275: 25342-25350Abstract Full Text Full Text PDF PubMed Scopus (156) Google Scholar) through the activation of Rap1 (11Schmitt J. M. Stork P. J. S. J. Biol. Chem. 2000; 275: 25342-25350Abstract Full Text Full Text PDF PubMed Scopus (156) Google Scholar). In exploring the mechanisms of β2AR-stimulated MAP kinase activation, we have found that some of the same signaling molecules required for receptor desensitization can also be intimately involved in the activation of the MAP kinase cascade. Following agonist activation, most GPCRs are phosphorylated by GPCR kinases (GRKs), with subsequent binding of β-arrestin to the phosphorylated receptor serving to interdict G protein coupling and signal transduction (5Lefkowitz R. J. J. Biol. Chem. 1998; 273: 18677-18680Abstract Full Text Full Text PDF PubMed Scopus (908) Google Scholar, 12Lin F. Krueger K. Kendall H. Daaka Y. Fredericks Z. Pitcher J. Lefkowitz R. J. Biol. Chem. 1997; 272: 31051-31057Crossref PubMed Scopus (207) Google Scholar, 13Luttrell L. M. Ferguson S. S. G. Daaka Y. Miller W. E. Maudsley S. Rocca G. J. D. Lin F. -T. Kawakatsu H. Owada K. Luttrell D. K. Caron M. G. Lefkowitz R. J. Science. 1999; 283: 655-661Crossref PubMed Scopus (1264) Google Scholar). However, in addition to its role in desensitization, β-arrestin can also participate in the events leading to MAP kinase activation. Binding of β-arrestin1 to the agonist-activated β2AR rapidly recruits c-Src to the receptor (12Lin F. Krueger K. Kendall H. Daaka Y. Fredericks Z. Pitcher J. Lefkowitz R. J. Biol. Chem. 1997; 272: 31051-31057Crossref PubMed Scopus (207) Google Scholar, 14Barak L. S. Ferguson S. S. Zhang J. Caron M. G. J. Biol. Chem. 1997; 272: 27497-27500Abstract Full Text Full Text PDF PubMed Scopus (397) Google Scholar). This recruitment appears to be mediated by an interaction between the amino-terminal proline-rich region of β-arrestin1 and the SH3 domain of c-Src (13Luttrell L. M. Ferguson S. S. G. Daaka Y. Miller W. E. Maudsley S. Rocca G. J. D. Lin F. -T. Kawakatsu H. Owada K. Luttrell D. K. Caron M. G. Lefkowitz R. J. Science. 1999; 283: 655-661Crossref PubMed Scopus (1264) Google Scholar, 15Miller W. E. Maudsley S. Ahn S. Khan K. D. Luttrell L. M. Lefkowitz R. J. J. Biol. Chem. 2000; 275: 11312-11319Abstract Full Text Full Text PDF PubMed Scopus (172) Google Scholar). The β3AR is a member of the βAR subfamily of GPCRs that is expressed predominantly in adipocytes. Because selective β3AR agonists have been shown to prevent or even reverse obesity and diabetes in various animal models (16Himms-Hagen J. Cui J. Danforth Jr. , E. Taatjes D. J. Lang S. S. Waters B. L. Claus T. H. Am. J. Physiol. 1994; 266: R1371-R1382Crossref PubMed Google Scholar, 17Collins S. Daniel K. W. Petro A. E. Surwit R. S. Endocrinology. 1997; 138: 405-413Crossref PubMed Scopus (187) Google Scholar, 18Sasaki N. Uchida E. Niiyama M. Yoshida T. Saito M. J. Vet. Med. Sci. 1998; 60: 465-469Crossref PubMed Scopus (27) Google Scholar), increased attention has been focused upon the molecular and physiological regulation of this receptor as a therapeutic target (19Collins, S. , and Surwit, R. S. (2000) Recent Prog. Horm. Res. , in press. Google Scholar). Early studies of β-adrenergic stimulation of adenylyl cyclase in adipocytes by Rodbell and colleagues (20Cooper D. Schlegel W. Lin M. Rodbell M. J. Biol. Chem. 1979; 254: 8927-8931Abstract Full Text PDF PubMed Google Scholar) indicated the presence of a PTX-sensitive component. In examining this issue, we showed that this effect is due to the presence of the adipocyte-specific β3AR and its ability to simultaneously couple to both Gs and Gi, leading to the activation of the cAMP-dependent protein kinase A and ERK1/2 pathways, respectively (9Soeder K. S. Snedden S. K. Cao W. Della Rocca G. J. Daniel K. W. Luttrell L. M. Collins S. J. Biol. Chem. 1999; 274: 12017-12022Abstract Full Text Full Text PDF PubMed Scopus (161) Google Scholar). Because GRK-mediated phosphorylation is necessary for β-arrestin binding (reviewed in Ref. 21Freedman N. Lefkowitz R. Recent Prog. Horm. Res. 1996; 51: 319-353PubMed Google Scholar), but the β3AR lacks sites for phosphorylation (22Liggett S. Freedman N. J. Schwinn D. A. Lefkowitz R. J. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 3665-3669Crossref PubMed Scopus (208) Google Scholar), we concluded that the β3AR must employ a novel mechanism of ERK activation. Here, we demonstrate that conserved proline-rich motifs in the third intracellular loop and carboxyl terminus of the β3AR directly recruit c-Src in a β3AR agonist- and PTX-sensitive manner. This interaction occurs specifically through the SH3 domain of c-Src. Our findings establish a new mechanism whereby some GPCRs can acquire ligand-induced tyrosine kinase activity by means of direct recruitment of Src kinases. -The β3AR agonist CL316, 243 was a gift from American Cyanamid Co. (Pearl River, NY). l- (−) -Isoproteronol and propranolol were from Sigma and selective c-Src inhibitor PP2 from Calbiochem. For plasmids Xa-2-Loop3 (Wt), Xa-2-Tail (Wt), Xa-2-MutL1 (L1), and Xa-2-MutT1 (T1), the wild-type or mutated third intracellular domain (amino acids 222–289) or the carboxyl terminus (amino acids 344–400) of mouse β3AR were cloned into PinPoint Xa-2 vector at HindIII and BglII sites under the control of the SV40 promoter. All plasmid constructs were verified by sequencing. GST fusion proteins of c-Src containing either the SH3 and SH2 domains (GST-SH3/SH2) or the SH2 domain alone (GST-SH2) were prepared as described previously (23Luttrell L. Della Rocca G. van Biesen T. Luttrell D. Lefkowitz R. J. Biol. Chem. 1997; 272: 4637-4644Abstract Full Text Full Text PDF PubMed Scopus (428) Google Scholar). C3H10T1/2 (T1/2) preadipocytes and COS-7 cells were grown in Dulbecco's modified Eagle's medium with 10% fetal bovine serum in 6-well dishes as detailed (13Luttrell L. M. Ferguson S. S. G. Daaka Y. Miller W. E. Maudsley S. Rocca G. J. D. Lin F. -T. Kawakatsu H. Owada K. Luttrell D. K. Caron M. G. Lefkowitz R. J. Science. 1999; 283: 655-661Crossref PubMed Scopus (1264) Google Scholar, 24Kliewer S. A. Lenhard J. M. Wilson T. M. Patel I. Morris D. C. Lehmann J. M. Cell. 1995; 83: 813-819Abstract Full Text PDF PubMed Scopus (1871) Google Scholar). Cells were transfected with HA-β3AR DNA (2 μg for T1/2 cells; 1 μg for COS-7 cells) and 5 μl of LipofectAMINE (Life Technologies, Inc. ). For T1/2, on day 2 cells were induced to differentiate (1 μmrosiglitazone, 0. 1 μm LGD1069, 200 nminsulin). Prior to each analysis, the density of receptor per cell was assessed by fluorescence-activated cell sorting. MAP kinase assays were performed as previously detailed (9Soeder K. S. Snedden S. K. Cao W. Della Rocca G. J. Daniel K. W. Luttrell L. M. Collins S. J. Biol. Chem. 1999; 274: 12017-12022Abstract Full Text Full Text PDF PubMed Scopus (161) Google Scholar) in cells that were serum-deprived for 24 h. Where indicated, some cells were treated with PTX (100 ng/ml, 16 h) propranolol (0. 1 μm, 5 min), CL316, 243 (10 μm), or isoproterenol (10 μm, 5 min). cAMP levels in whole cells were measured as described previously (9Soeder K. S. Snedden S. K. Cao W. Della Rocca G. J. Daniel K. W. Luttrell L. M. Collins S. J. Biol. Chem. 1999; 274: 12017-12022Abstract Full Text Full Text PDF PubMed Scopus (161) Google Scholar). Confocal microscopy was performed on a Zeiss LSM510 laser scanning microscope using a Zeiss 63X 1. 4 numerical aperture water immersion lens, and fluorescent signals were collected (14Barak L. S. Ferguson S. S. Zhang J. Caron M. G. J. Biol. Chem. 1997; 272: 27497-27500Abstract Full Text Full Text PDF PubMed Scopus (397) Google Scholar). Three independent experiments were performed, and 10 or more fields/sample were analyzed in each experiment. The biotinylated fusion proteins for the wild-type or mutated Xa-2-β3AR Loop3 or Xa-2-β3AR Tail were expressed and purified (Promega). For in vitro binding, 2 μg of purified biotinylated fusion protein was mixed with 4 μg of GST-Src-SH3/2 or GST-Src-SH2 fusion proteins and incubated in phosphate-buffered saline containing 1% bovine serum albumin, 5% glycerol, and 0. 1% Nonidet P-40. After 16 h at 4 °C, the reactions were terminated by washing the immobilized complexes with 30 volumes of ice-cold phosphate-buffered saline containing 5% glycerol and 0. 1% Nonidet P-40. The supernatant was removed, and 50 μl of 2× SDS-polyacrylamide gel electrophoresis sample buffer was added to each reaction. The biotinylated proteins were resolved by 4–20% SDS-acrylamide gradient gel electrophoresis (Novagen), transferred to nitrocellulose membranes, and identified by staining with streptavidin-conjugated alkaline phosphatase. Immunoprecipitations of HA-tagged β2AR and β3AR from intact cells and immunoblotting for co-precipitated proteins were performed as described previously (25Luttrell L. M. Hawes B. E. van Biesen T. Luttrell D. K. Lansing T. J. Lefkowitz R. J. J. Biol. Chem. 1996; 271: 19443-19450Abstract Full Text Full Text PDF PubMed Scopus (494) Google Scholar). Activation of the Ras-dependent ERK cascade by many GPCRs requires Src kinase activity (13Luttrell L. M. Ferguson S. S. G. Daaka Y. Miller W. E. Maudsley S. Rocca G. J. D. Lin F. -T. Kawakatsu H. Owada K. Luttrell D. K. Caron M. G. Lefkowitz R. J. Science. 1999; 283: 655-661Crossref PubMed Scopus (1264) Google Scholar, 25Luttrell L. M. Hawes B. E. van Biesen T. Luttrell D. K. Lansing T. J. Lefkowitz R. J. J. Biol. Chem. 1996; 271: 19443-19450Abstract Full Text Full Text PDF PubMed Scopus (494) Google Scholar). For the β2AR, ERK activation depends on the delivery of β-arrestin-bound c-Src to the receptor (13Luttrell L. M. Ferguson S. S. G. Daaka Y. Miller W. E. Maudsley S. Rocca G. J. D. Lin F. -T. Kawakatsu H. Owada K. Luttrell D. K. Caron M. G. Lefkowitz R. J. Science. 1999; 283: 655-661Crossref PubMed Scopus (1264) Google Scholar). However, it is unclear whether other GPCRs utilize this same mechanism. As shown in Fig. 1, β3AR-mediated ERK activation similarly requires Src kinase activity, as demonstrated by its concentration-dependent sensitivity to the Src-specific tyrosine kinase inhibitor, PP2. Complete inhibition was achieved within the range of 1 to 5 μm; a concentration previously established to selectively inhibit Src kinase (8Maudsley S. Pierce K. L. Zamah A. M. Miller W. E. Ahn S. Daaka Y. Lefkowitz R. J. Luttrell L. M. J. Biol. Chem. 2000; 275: 9572-9580Abstract Full Text Full Text PDF PubMed Scopus (386) Google Scholar, 26Yoshizumi M. Abe J. -i. Haendeler J. Huang Q. Berk B. C. J. Biol. Chem. 2000; 275: 11706-11712Abstract Full Text Full Text PDF PubMed Scopus (237) Google Scholar). Inhibition of β3AR-mediated ERK activation was also observed when the C-terminal Src kinase was co-expressed with β3AR (data not shown). Because GRK-mediated phosphorylation of receptors is necessary for β-arrestin binding (21Freedman N. Lefkowitz R. Recent Prog. Horm. Res. 1996; 51: 319-353PubMed Google Scholar), but the β3AR is not phosphorylated by GRKs, we hypothesized that agonist stimulation of β3AR would not lead to β-arrestin binding. This hypothesis is confirmed as illustrated in Fig. 2, which compares the effects of agonist stimulation on the cellular distribution of a chimeric β-arrestin 2-GFP in HEK-293 cells expressing either the human β2AR or the mouse β3AR. Isoprenaline (10 μm) stimulation of the β2AR promotes the rapid translocation of β-arrestin 2-GFP from a diffuse cytosolic distribution to the plasma membrane where it aggregates with the receptor in membrane-associated puncta (14Barak L. S. Ferguson S. S. Zhang J. Caron M. G. J. Biol. Chem. 1997; 272: 27497-27500Abstract Full Text Full Text PDF PubMed Scopus (397) Google Scholar). In contrast, stimulation of cells expressing the mouse β3AR with the selective β3AR agonist CL316, 243 (5 μm) fails to induce β-arrestin 2-GFP translocation. Thus, although ERK activation is to the β2AR, the β3AR occurs the of complexes between β3AR and of β2AR, but not β3AR, in recruitment of β-arrestin 2-GFP to the plasma expressing β2AR or β3AR and β-arrestin 2-GFP were for 10 with 10 μm isoproterenol or 5 μm The distribution of β-arrestin 2-GFP and agonist stimulation was by laser microscopy (13Luttrell L. M. Ferguson S. S. G. Daaka Y. Miller W. E. Maudsley S. Rocca G. J. D. Lin F. -T. Kawakatsu H. Owada K. Luttrell D. K. Caron M. G. Lefkowitz R. J. Science. 1999; 283: 655-661Crossref PubMed Scopus (1264) Google Scholar). shown are from 1 of 3 independent We previously showed that c-Src interacts with motifs in the β-arrestin terminus and the SH3 domain of although the c-Src domain also to this binding (13Luttrell L. M. Ferguson S. S. G. Daaka Y. Miller W. E. Maudsley S. Rocca G. J. D. Lin F. -T. Kawakatsu H. Owada K. Luttrell D. K. Caron M. G. Lefkowitz R. J. Science. 1999; 283: 655-661Crossref PubMed Scopus (1264) Google Scholar). although the β3AR not recruit β-arrestin, of this receptor conserved in both the third intracellular domain and the carboxyl terminus that are from the of these in each domain the which the for SH3 domain binding H. S. D. C. Cell. 1994; Full Text PDF PubMed Scopus Google Scholar, R. D. Cell. 1995; Full Text PDF PubMed Scopus Google Scholar, Proc. Natl. Acad. Sci. U. S. A. 1996; PubMed Scopus Google Scholar). We the hypothesis that these proline-rich motifs within the β3AR directly recruit SH3 proteins to the the for β-arrestin to as an adapter we whether β3AR directly recruit Src kinases to activate the ERK pathway in the absence or presence of β-arrestin in COS-7 cells, which β-arrestin L. Ferguson S. S. Zhang J. Lin Lefkowitz R. J. Caron M. G. L. S. 1997; 51: PubMed Scopus Google Scholar). As shown in Fig. 3 agonist in the co-precipitation of c-Src with the β2AR in the presence of co-expressed β-arrestin. As from studies (13Luttrell L. M. Ferguson S. S. G. Daaka Y. Miller W. E. Maudsley S. Rocca G. J. D. Lin F. -T. Kawakatsu H. Owada K. Luttrell D. K. Caron M. G. Lefkowitz R. J. Science. 1999; 283: 655-661Crossref PubMed Scopus (1264) Google Scholar), the of β-arrestin ERK phosphorylation under these In contrast, the of β-arrestin effect on mediated by the β3AR. β3AR agonist-dependent co-precipitation of c-Src and ERK1/2 activation was which not the presence of β-arrestin Src that co-precipitated with β2AR and β3AR was also in its activated the physiological of of the β3AR is the a is whether the β3AR directly recruits Src kinase in adipocytes as observed in COS-7 We performed co-precipitation experiments in the mouse cell C3H10T1/2 J. M. Lenhard J. M. S. A. J. Biol. Chem. 1997; 272: Full Text Full Text PDF PubMed Scopus Google Scholar). As shown in Fig. 4 by day 4 of C3H10T1/2 cells the adipocyte-specific β3AR and the protein Proc. Natl. Acad. Sci. U. S. A. 83: PubMed Scopus Google Scholar, F. Sci. 1996; 17: Full Text PDF PubMed Scopus Google Scholar). Fig. 4 that the agonist CL316, 243 is of ERK activation in both cells the and in the transfected cells, but ERK activation was abolished by of Gi with Fig. 4 as observed in COS-7 cells, Src kinase with the HA-β3AR in C3H10T1/2 and this interaction is both agonist- and These that the β3AR can the recruitment of c-Src. whether binding between proline-rich motifs in the β3AR and the c-Src SH3 domain be for this we whether from these regions of the β3AR, as shown in Fig. 5 would to fusion proteins in As shown in Fig. 5 biotinylated fusion proteins from both the third intracellular domain and the carboxyl terminus of the wild-type β3AR to the but not to the SH2 fusion was interaction with GST with an SH3 of the β3AR Loop3 and Tail in which was for in the PXXP motifs were able to with the In we found that the wild-type β3AR Loop3 and Tail c-Src and from whole cell of HEK-293 cells shown). these data that proline-rich motifs in both Loop3 and the Tail of the β3AR the to SH3 the role of the β3AR proline-rich motifs in activation of the ERK were in which these motifs were by containing the of Loop3 acids to or mutations were expressed in COS-7 cells and for the ability to c-Src and to induce ERK1/2 phosphorylation and cAMP As shown in Fig. or of the PXXP motifs in either the third intracellular loop or the carboxyl terminus in a of β3AR-mediated c-Src binding and ERK activation from β3AR-mediated stimulation of adenylyl Fig. A that c-Src co-precipitated with wild-type β3AR in an agonist-dependent whereas co-precipitation of c-Src with each of the receptors was effects were observed for β3AR-mediated ERK1/2 activation, which was abolished by the and mutations In contrast, β3AR-mediated of cAMP was by of the PXXP motifs These data that the ability of the β3AR to activation of the ERK but not its ability to with Gs protein and stimulate the cAMP is upon the of the PXXP motifs in the third intracellular domain and the carboxyl terminus of the of these motifs is to to SH3 domains in and of either the agonist-dependent of complexes between the β3AR and c-Src when the receptors are expressed in intact The for intact PXXP motifs in both the third intracellular loop and the carboxyl terminus of the β3AR for agonist-dependent Src co-precipitation and ERK activation is not but it that a novel containing at activated c-Src and domains of the β3AR is on the receptor to this signaling cascade. However, the of this is and the of the interaction and The by the β2AR and β3AR to recruit Src kinases the flexibility that the mechanisms of G protein receptor and activation of tyrosine protein kinases by In the of the β2AR, G protein coupling and ERK activation Src recruitment requires β-arrestin binding, an that simultaneously protein coupling and of the receptor from the cell In contrast, the β3AR is expressed in adipocytes where it is by in to the for and A. Rev. 1997; PubMed Scopus Google Scholar). its is for β3AR desensitization, in of stimulation such as to is that the activation of the cAMP-dependent protein kinase A and MAP kinase have for E. P. Science. 1996; 274: PubMed Scopus Google Scholar, M. M. D. M. J. Biol. Chem. 1997; 272: Full Text Full Text PDF PubMed Scopus Google Scholar, P. 1998; PubMed Scopus Google Scholar, P. Z. R. M. B. Cell. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar), the and effects of β3AR S. Daniel K. W. Petro A. E. Surwit R. S. Endocrinology. 1997; 138: 405-413Crossref PubMed Scopus (187) Google Scholar, Wilson Wilson S. Nature. PubMed Scopus Google Scholar). of SH3 domain binding motifs within the intracellular domains of the receptor the adapter protein role of β-arrestin within the Src recruitment and ERK activation to of receptor We for the and Caron for the β-arrestin 2-GFP and for the